Trials / Completed
CompletedNCT02679469
A Single-center, Open-label, Single-dose Study Investigating the Safety, Tolerability, and Pharmacokinetic Properties of Nalmefene 10 mg Tablets in Healthy Japanese Male Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 7 (actual)
- Sponsor
- Otsuka Pharmaceutical Co., Ltd. · Industry
- Sex
- Male
- Age
- 20 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
The safety, tolerability, and pharmacokinetics of nalmefene at a single oral dose of 10 mg in healthy Japanese male subjects will be evaluated.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | nalmefene hydrochloride 10 mg |
Timeline
- Start date
- 2016-02-01
- Primary completion
- 2016-03-01
- Completion
- 2016-03-01
- First posted
- 2016-02-10
- Last updated
- 2017-04-18
- Results posted
- 2017-04-18
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT02679469. Inclusion in this directory is not an endorsement.